Sabrina Khan

Chief Financial Officer at Aptorum Group Limited (Nasdaq/Euronext Paris: APM)
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Hong Kong SAR, HK

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United Kingdom
    • Biotechnology Research
    • 1 - 100 Employee
    • Chief Financial Officer
      • 2017 - Present

      Aptorum Group (Nasdaq: APM/Euronext Paris: APM) is an internationally integrated life science and medical innovations company dedicated to acquiring, developing, and commercializing novel pharmaceutical and biotechnology products to enhance patient care around the world. Aptorum Group develops its businesses across two major areas: (a) therapeutic drug products, and (ii) medical robotics and artificial intelligence. Aptorum Group (Nasdaq: APM/Euronext Paris: APM) is an internationally integrated life science and medical innovations company dedicated to acquiring, developing, and commercializing novel pharmaceutical and biotechnology products to enhance patient care around the world. Aptorum Group develops its businesses across two major areas: (a) therapeutic drug products, and (ii) medical robotics and artificial intelligence.

    • Singapore
    • Financial Services
    • 300 - 400 Employee
    • Financial Controller - Asia
      • 2016 - 2017

      St. James’s Place Wealth Management is a FTSE 100 company with £100.6bn of client funds under management. Its Asia hub is one of the largest wealth management companies serving the international community living and/or working in Asia with strong presence in Asia including Hong Kong, China (Shanghai, Shenzhen & Beijing) and Singapore. St. James’s Place Wealth Management is a FTSE 100 company with £100.6bn of client funds under management. Its Asia hub is one of the largest wealth management companies serving the international community living and/or working in Asia with strong presence in Asia including Hong Kong, China (Shanghai, Shenzhen & Beijing) and Singapore.

    • Hong Kong
    • Wellness and Fitness Services
    • 100 - 200 Employee
    • Senior Finance Manager
      • 2013 - 2016

      Neo Derm is the largest medical aesthetic firm in Asia. Since its inception in 1997, Neo Derm has now become an industry leader with over 1,000 employees. Its outstanding achievement was also honoured in 2008 by the HKMA Quality Award - Gold Award, as the company became the first beauty group to be given this award by the Hong Kong Management Association. Neo Derm is the largest medical aesthetic firm in Asia. Since its inception in 1997, Neo Derm has now become an industry leader with over 1,000 employees. Its outstanding achievement was also honoured in 2008 by the HKMA Quality Award - Gold Award, as the company became the first beauty group to be given this award by the Hong Kong Management Association.

    • Senior Finance Manager
      • 2009 - 2013

      Global Cord Blood Corporation (NYSE: CO, formerly known as China Cord Blood Corporation) is a life sciences enterprise dedicated to the storage of umbilical cord blood stem cells. It is the first cord blood banking operator approved by the Ministry of Health (MOH, now recognized as National Health and Family Planning Commission, or NHFPC), the People's Republic of China, to engage in the cord blood banking business. It is also the largest cord blood banking operator in China, and is one of the founders of the highly recognized non-profit organization - AsiaCORD (Asia Cord Blood Bank) Organization. Show less

Education

  • The University of Hong Kong

Community

You need to have a working account to view this content. Click here to join now